Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

ALL OF IT is a show about culture and its consumers. ALL OF IT is a show about culture and context. ALL OF IT is a show about culture and the culture. Our aim is to engage the thinkers, doers, makers, ...

Notable: Seattle is up to 54% to earn the No. 1 seed after beating the Panthers on Sunday, according to The Athletic's playoff predictor. If they beat the Niners on Saturday night, they'll win the No.